Cerebral function in diabetes mellitus

Greene DA, Lattimer SA, Sima AAF (1987) Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 316: 599–606 Strowig S, Raskin P (1992) Glycemic control and diabetic complications. Diabetes Care 15: 1126–1140 Brown MJ, Ashbury AK (1984) Diabetic neuropathy. Ann Neurol 15: 2–12 Niakan E, Harati Y, Comstock JP (1986) Diabetic autonomic neuropathy. Metabolism 35: 224–234 Vinik AI, Holland MT, Le Beau JM, Liuzzi FJ, Stansberry KB, Colen LB (1992) Diabetic neuropathies. Diabetes Care 15: 1926–1975 Mooradian AD (1988) Diabetes and the central nervous system. Endocr Rev 9: 346–356 McCall AL (1992) The impact of diabetes on the CNS. Diabetes 41: 557–570 Chu PC, Lin MT, Shian LR, Leu SY (1986) Alterations in physiologic functions and brain monoamine content in streptozotocin-diabetic rats. Diabetes 35: 481–485 Broderick PA, Jacoby JH (1988) Serotinergic function in diabetic rats: psychotherapeutic implications. Biol Psychiatry 24: 234–239 Mooradian AD, Perryman K, Fitten J, Kavonian GD, Mor-ley JE (1988) Cortical function in elderly non-insulin dependent diabetic patients. Behavioral and electrophysiologic studies. Arch Intern Med 148: 2369–2372 Haumont D, Dorchy H, Pelc S (1979) EEG abnormalities in diabetic children. Clin Pediatr 18: 750–753 Dejgaard A, Gade A, Larsson H, Balle V, Parving A, Parving HH (1991) Evidence for diabetic encephalopathy. Diabetic Med 8: 162–167 Pozzessere G, Valle E, De Crignis S et al. (1991) Abnormalities of cognitive functions in IDDM revealed by P300 event-related potential analysis. Diabetes 40: 952–958 Roehmholdt ME, Palumbo PJ, Wishnant JP, Elveback LR (1983) Transient ischemic attack and stroke in a community-based diabetic cohort. Mayo Clin Proc 58: 56–58 Abbott RD, Donahue RP, Macmahon SW, Reed DM, Yano K (1987) Diabetes and the risk of stroke. The Honolulu heart program. JAMA 257: 949–952 Sutherland GR, Peeling J, Sutherland E et al. (1992) Forebrain ischemia in diabetic and nondiabetic BB rats studied with 31P magnetic resonance spectroscopy. Diabetes 41: 1328–1334 Foster DW (1991) Diabetes mellitus. In: Wilson JD, Braunwald E, Isselbacher KJ et al. (eds) Harrison's principles of internal medicine. 12th edn. McGraw-Hill Inc., New York, pp 1749–1753 Kreis R, Ross BD (1992) Cerebral metabolic disturbances in patients with subacute and chronic diabetes mellitus: detection with proton MR spectroscopy. Radiology 184: 123–130 Heller S, Ward JD (1993) Neurologic consequences of hypoglycemia and pathogenic mechanisms involved in diabetic neuropathy. Curr Opin Neurol Neurosurg 6: 423–428 Veneman T, Mitrakou A, Mokan M, Cryer P, Gerich J (1993) Induction of hypoglycemia unawareness by asymptomatic noctural hypoglycemia. Diabetes 42: 1233–1237 Low PA, Tuck PR, Takeuchi M (1987) Nerve microenvironment in diabetic neuropathy. In: Dyck PJ, Thomas PK, Asbury AK, Winegard AI, Porte D (eds) Diabetic neuropathy. Saunders, Philadelphia, pp 289–298 Greene DA, Lattimer SA (1988) Pathogenesis and prevention of diabetic neuropathy. Diabetes Metab Rev 4: 201–221 Welsh B, Wecker L (1991) Effects of streptozotocin-induced diabetes on acetylcholine metabolism in rat brain. Neurochem Res 16: 453–460 Trulson ME, Himmel CD (1985) Effects of insulin and streptozotocin-induced diabetes on brain norepinephrine metabolism in rats. J Neurochem 44: 1873–1876 Di Giulio AM, Tenconi B, La Croix R et al. (1989) Denervation and hyperinnervation in the nervous system of diabetic animals II: monoaminergic and peptidergic alterations in diabetic encephalopathy. J Neurosci Res 24: 362–368 Lackovic Z, Salkovic M, Kuci Z, Relja M (1990) Effect of long-lasting diabetes mellitus on rat and human brain monoamines. J Neurochem 54: 143–147 Bellush LL, Reid SG (1991) Altered behavior and neurochemistry during short-term insulin withdrawal in streptozotocin-induced diabetic rats. Diabetes 40: 217–222 Salkovic M, Lackovic Z (1992) Brain D1 dopamine receptor in alloxan-induced diabetes. Diabetes 41: 1119–1121 Lozovsky D, Saller CF, Kopin IJ (1981) Dopamine receptor binding is increased in diabetic rats. Science 214: 1031–1033 Abbracchio MP, Di Luca M, Di Giulio AM, Cattabeni F, Tenconi B, Gorio A (1989) Denervation and hyperinnervation in the nervous system of diabetic animals III: functional changes of G proteins in diabetic encephalopathy. J Neurosci Res 24: 517–523 Rowland NE, Bellush LL (1989) Diabetes mellitus: stress, neurochemistry and behavior. Neurosci Biobehav Rev 13: 199–206 Lustman PJ, Griffith LS, Clouse RE, Cryer PE (1986) Psychiatric illness in diabetes mellitus. J Nerv Ment Disease 174: 736–742 Lustman PJ, Griffith LS, Gavard JA, Clouse RE (1992) Depression in adults with diabetes. Diabetes Care 15: 1631–1639 Leedom L, Meehan WP, Procci W, Zeidler A (1991) Symptoms of depression in patients with type II diabetes mellitus. Psychosomatics 32: 280–286 Sima AAF, Zhang WX, Cherian PV, Chakrabarti S (1992) Impaired visual evoked potential and primary axonopathy in the optic nerve in the diabetic BB/W-rat. Diabetologia 35: 602–607 Kamijo M, Cherian PV, Sima AAF (1993) The preventive effect of aldose reductase inhibition on diabetic optic neuropathy in the BB/W-rat. Diabetologia 36: 893–898 Pozzessere G, Rizzo PA, Valle E et al. (1988) Early detection of neurological involvement in IDDM and NIDDM. Multimodal evoked potentials versus metabolic control. Diabetes Care 11: 473–480 Martini A, Comacchio F, Magnavita V (1991) Auditory brainstem and middle latency evoked responses in the clinical evaluation of diabetes. Diabet Med 8 [Suppl]: S74-S77 Nakamura R, Noritake M, Hosoda Y, Kamakura K, Nagata N, Shibasaki H (1992) Somatosensory conduction delay in central and peripheral nervous system of diabetic patients. Diabetes Care 15: 532–535 Donald MW, Williams Erdahl DL, Surridge DHC et al. (1984) Functional correlates of reduced central conduction velocity in diabetic subjects. Diabetes 33: 627–633 Khardori R, Soler NG, Good DC, Devlesc Howard AB, Broughton D, Walbert J (1986) Brainstem auditory and visual evoked potentials in type 1 (insulin-dependent) diabetic patients. Diabetologia 29: 362–365 Polich J, Howard L, Star A (1983) P300 and digit span. Curr Opin Neurol Neurosurg 6: 423–428 Surwillo WW (1984) P300 latency and digit span. Psychophysiology 21: 708–709 Hillyard SA, Kutas M (1983) Electrophysiology of cognitive processing. Annu Rev Psychol 34: 33–61 Luse SA, Gerritsen GC, Dulin WE (1970) Cerebral abnormalities in diabetes mellitus: an ultrastructural study of the brain in early-onset diabetes mellitus in the Chinese hamster. Diabetologia 6: 192–198 Mukai N, Hori S, Pomeroy M (1980) Cerebral lesions in rats with streptozotocin-induced diabetes. Acta Neuropathol (Berl) 51: 79–84 Jakobsen J, Sidenius P, Gundersen HJG, Osterby R (1987) Quantitative changes of cerebral neocortical structure in insulin-treated long-term streptozotocin-induced diabetes in rats. Diabetes 36: 597–601 Junker U, Jaggi C, Bestetti G, Rossi GL (1985) Basement membrane of hypothalamus and cortex capillaries from normotensive and spontaneously hypertensive rats with streptozotocin-induced diabetes. Acta Neuropathol (Berl) 65: 202–208 Reske-Nielsen E, Lundbaek K, Rafaelsen OJ (1965) Pathological changes in the central and peripheral nervous system of young long-term diabetics. Diabetologia 1: 233–241 Bale RN (1973) Brain damage in diabetes mellitus. Br J Psychiatry 122: 337–341 Cox DJ, Gonder-Frederick L (1992) Major developments in behavioral diabetes research. J Consult Clin Psychol 60: 628–638 Ryan CM (1988) Neurobehavioral complications of type I diabetes. Diabetes Care 11: 86–93 Ryan CM, Williams TM, Orchard TJ, Finegold DN (1992) Psychomotor slowing is associated with distal symmetrical polyneuropathy in adults with diabetes mellitus. Diabetes 41: 107–113 Ryan CM, Williams TM, Finegold DN, Orchard TJ (1993) Cognitive dysfunction in adults with type 1 (insulin-dependent) diabetes mellitus of long duration: effects of recurrent hypoglycaemia and other chronic complications. Diabetologia 36: 329–334 Richardson JT (1990) Cognitive function in diabetes mellitus. Neurosci Biobehav Rev 14: 385–388 Deary IJ, Crawford JR, Hepburn DA, Langan SJ, Blackmore LM, Frier BM (1993) Severe hypoglycaemia and intelligence in adult patients with insulin-treated diabetes. Diabetes 42: 341–344 Reaven GM, Thompson LW, Nahum D, Haskins E (1990) Relationship between hyperglycaemia and cognitive function in older NIDDM patients. Diabetes Care 13: 16–21 Ack M, Miller I, Weil WB (1961) Intelligence of children with diabetes mellitus. Pediatrics 28: 764–770 Ryan CM, Vega A, Drash A (1985) Cognitive deficits in adolescents who developed diabetes early in life. Pediatrics 75: 921–927 Rovet JF, Ehrlich RM, Hoppe M (1987) Intellectual deficits associated with early onset of insulin dependent diabetes mellitus in children. Diabetes Care 10: 510–515 Fowler MG, Johnson MP, Atkinson SS (1985) School achievement and absence in children with chronic health conditions. J Pediatr 106: 683–687 Golden MP, Ingersoll GM, Brack CJ, Russel BA, Wright JC, Huberty TJ (1989) Longitudinal relationship of asymptomatic hypoglycemia to cognitive function in IDDM. Diabetes Care 12: 89–93 Reichard P, Berglund A, Britz A, Levander S, Rosenqvist U (1991) Hypoglycaemic episodes during intensified insulin treatment: increased frequency but no effect on cognitive function. J Intern Med 229: 9–16 DCCT Research Group (1991) Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med 90: 450–459 Wredling R, Levander S, Adamson U, Lins PE (1990) Permanent neuropsychological impairment after recurrent episodes of severe hypoglycaemia in man. Diabetologia 33: 152–157 Langan SJ, Deary IJ, Hepburn DA, Frier BM (1991) Cumulative cognitive impairment following recurrent severe hypoglycaemia in adult patients with insulin-treated diabetes mellitus. Diabetologia 34: 337–344 Rennick PM, Wider RM, Sargent J, Ashley BJ (1968) Retinopathy as an indicator of cognitive-perceptual-motor impairment in diabetic adults (Summary). Proc 76th Annu Conv AM Psychol Assoc: 473–474 Popkin MK, Callies AL, Lentz RD, Colon EA, Sutherland DE (1988) Prevalence of major depression, simple phobia, and other psychiatric disorders in patients with long-standing type I diabetes mellitus. Arch Gen Psychiatry 45: 64–68 Surridge DHC, Williams Erdahl DL, Lawson JS et al. (1984) Psychiatric aspects of diabetes mellitus. Br J Psychiat 145: 269–276 Gavard JA, Lustman PJ, Clouse RE (1993) Prevalence of depression in adults with diabetes. Diabetes Care 16: 1167–1178 Rodin G, Voshart K (1986) Depression in the medically ill: an overview. Am J Psychiatry 143: 696–705 Lustman PJ, Harper GW, Griffith LS, Clouse RE (1986) Use of the diagnostic interview schedule in patients with diabetes mellitus. J Nerv Ment Disease 174: 743–746 Johnson PC, Brendel K, Meezan E (1982) Thickened cerebral cortical capillary basement membranes in diabetics. Arch Pathol Lab Med 106: 214–217 Duckrow RB, Beard DC, Brennan RW (1987) Regional cerebral blood flow decreases during chronic and acute hyperglycemia. Stroke 18: 52–58 Harik SI, LaManna JC (1988) Vascular perfusion and blood-brain glucose transport in acute and chronic hyperglycemia. J Neurochem 51: 1924–1929 Kikano GE, La Manna JC, Harik SI (1989) Brain perfusion in acute and chronic hyperglycemia in rats. Stroke 20: 1027–1031 Rodriguez G, Nobili F, Celestino MA et al. (1993) Regional cerebral blood flow and cerebrovascular reactivity in IDDM. Diabetes Care 16: 462–468 Grill V, Gutniak M, Björkman O et al. (1990) Cerebral blood flow and substrate utilization in insulin-treated diabetic subjects. Am J Physiol 258: E813-E820 Kastrup J, Rorsgaard S, Parving HH, Lassen NA (1986) Impaired autoregulation of cerebral blood flow in long-term type I (insulin-dependent) diabetic patients with nephropathy and neuropathy. Clin Physiol 6: 549–559 Albert SG, Gomez CR, Russeli S, Chaitman BR, Bernbaum M, Kong BA (1993) Cerebral and ophthalmic artery hemodynamic responses in diabetes mellitus. Diabetes Care 16: 476–482 Mayhan WG, Simmons LK, Sharpe GM (1991) Mechanism of impaired response of cerebral arterioles during diabetes mellitus. Am J Physiol 260: H319-H326 Pelligrino DA, Albrecht RF (1991) Chronic hyperglycemic diabetes in the rat is associated with a selective impairment of cerebral vasodilatory responses. J Cereb Blood Flow Metab 11: 667–677 Wirsén A, Tallroth G, Lindgren M, Agarhd CD (1992) Neuropsychological performance differs betweeen type I diabetic and normal men during insulin-induced hypoglycaemia. Diabetic Med 9: 156–165 Hoffman RG, Speelman DJ, Hinnen DA, Conley KL, Guthrie RA, Knapp RK (1989) Changes in cortical functioning with acute hypoglycaemia and hyperglycemia in type I diabetes. Diabetes Care 12: 193–197 Blackman JD, Towle VL, Lewis GF, Spire JP, Polonsky KS (1990) Hypoglycemic thresholds for cognitive dysfunction in humans. Diabetes 39: 828–835 Auer RN (1986) Progress review: hypoglycemic brain damage. Stroke 17: 699–708 Auer RN, Olsson Y, Siesjö BK (1984) Hypoglycemic brain injury in the rat. Correlation of density of brain damage with the EEG isoelectric time: a quantative study. Diabetes 33: 1090–1098 Wieloch T (1985) Hypoglycaemia-induced neuronal damage prevented by an N-methyl-D-aspartate antagonist. Science 230: 681–683 Choi DW (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1: 623–634 Siesjö BK, Bengtsson F (1989) Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia hypoglycaemia and spreading depression: a unifying hypothesis. J Cerb Blood Flow Metab 9: 127–140 Araki N, Greenberg JH, Sladky JT, Uematsu D, Karp A, Reivich M (1992) The effect of hyperglycemia on intracellular calcium in stroke. J Cereb Blood Flow Metab 12: 469–476 Meldrum B, Garthwaite J (1990) Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Parmacol Sci 11: 379–387 Young AB, Fagg GE (1990) Excitatory amino acid receptors in the brain: membrane binding and receptor autoradiographic approaches. Trends Pharmacol Sci 11: 126–133 Papagapiou MP, Auer RN (1990) Regional neuroprotective effects of the NMDA receptor antagonist MK-801 (Dizocilpine) in hypoglycemic brain damage. J Cereb Blood Flow Metab 10: 270–276 Pizzi M, Ribola M, Valerio A, Memo M, Spano PF (1991) Various Ca2+ entry blockers prevent glutamate-induced neurotoxicity. Eur J Pharmacol 209: 169–173 Mooradian AD, Morin AM (1991) Brain uptake of glucose in diabetes mellitus: the role of glucose transporters. Am J Med Sci 301: 173–177 Knudsen GM, Jakobsen J, Barry DI, Compton AM, Tomlinson DR (1989) Myo-inositol normalizes decreased sodium permeability of the blood-brain barrier in streptozotocin diabetes. Neuroscience 29: 773–777 Crandall EA, Fernstrom JD (1983) Effect of experimental diabetes on the levels of aromatic and branched-chain amino acids in rat blood and brain. Diabetes 32: 222–230 Trachtman H, Futterweit S, Sturman JA (1992) Cerebral taurine transport is increased during streptozotocin-induced diabetes in rats. Diabetes 41: 1130–1140 Pardridge WM, Triguero D, Farrell CR (1990) Downregulation of blood-brain barrier glucose transporter in experimental diabetes. Diabetes 39: 1040–1044 Gutniak M, Blomqvist G, Widén L, Stone-Elander S, Hamberger B, Grill V (1990) D-[U-11C] glucose uptake and metabolism in the brain of insulin-treated diabetic subjects. Am J Physiol 258: E805-E812 Bruhn H, Michaelis T, Merboldt KD, Hänicke W, Gyngell ML, Frahm J (1991) Monitoring cerebral glucose in diabetics by proton MRS. Lancet 337: 745–746 Hofer RE, Lanier WL (1991) Effects of insulin on blood, plasma, and brain glucose in hyperglycemic diabetic rats. Stroke 22: 505–509 Leong SF, Leung TKC (1991) Diabetes induced by streptozotocin causes reduced Na-K ATPase in the brain. Neurochem Res 16: 1161–1165